The Contribution of Kidney Disease to Cognitive Impairment in Patients with Type 2 Diabetes

Overview

Journal Curr Diab Rep

Publisher Current Science

Specialty Endocrinology

Date 2020 Aug 29

PMID 32857243

Citations 7

Authors

Shivani Ghoshal

Nicholette D Allred

Barry I Freedman

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: This review focuses on the relationships between diabetes, cognitive impairment, and the contribution of kidney disease.

Recent Findings: We review the independent contributions of parameters of kidney disease, including albuminuria, glomerular filtration, bone/mineral metabolism, and vitamin D synthesis, on cognitive performance in patients with diabetes. Potential pathophysiologic mechanisms underlying these associations are discussed highlighting gaps in existing knowledge. Finally, effects of the dialysis procedure on the brain and cognitive performance are considered. Emphasis is placed on novel non-invasive screening tools with the potential to preserve cerebral perfusion during hemodialysis and limit cognitive decline in patients with diabetic ESKD. Patients with type 2 diabetes and advanced chronic kidney disease suffer a higher prevalence of cognitive impairment. This is particularly true in patients with diabetes and end-stage kidney disease (ESKD).

Citing Articles

Glymphatic system dysfunction in nondialysis-dependent ESRD patients with diabetic kidney disease: associations with clinical characteristics and cognitive function.

Yu B, Yang W, Song L, Li M, Xu B, Wang Z Ren Fail. 2024; 46(2):2425160.

PMID: 39506907 PMC: 11544731. DOI: 10.1080/0886022X.2024.2425160.

Association of blood glucose change with postoperative delirium after coronary artery bypass grafting in patients with diabetes mellitus: a study of the MIMIC-IV database.

Wang F, Mei X Front Endocrinol (Lausanne). 2024; 15:1400207.

PMID: 38966222 PMC: 11222311. DOI: 10.3389/fendo.2024.1400207.

Elucidating the Link Between Anxiety/Depression and Alzheimer's Dementia in the Australian Imaging Biomarkers and Lifestyle (AIBL) Study.

Ma L, Tan E, Bush A, Masters C, Goudey B, Jin L J Epidemiol Glob Health. 2024; 14(3):1130-1141.

PMID: 38896210 PMC: 11442410. DOI: 10.1007/s44197-024-00266-w.

Connections between Cognitive Impairment and Atrial Fibrillation in Patients with Diabetes Mellitus Type 2.

Militaru M, Lighezan D, Tudoran C, Militaru A Biomedicines. 2024; 12(3).

PMID: 38540284 PMC: 10967964. DOI: 10.3390/biomedicines12030672.

Risk of Dementia Among Patients With Diabetes in a Multidisciplinary, Primary Care Management Program.

Wang K, Zhao S, Lee E, Yau S, Wu Y, Hung C JAMA Netw Open. 2024; 7(2):e2355733.

PMID: 38345817 PMC: 10862158. DOI: 10.1001/jamanetworkopen.2023.55733.

References

Ghoshal S, Freedman B . Mechanisms of Stroke in Patients with Chronic Kidney Disease. Am J Nephrol. 2019; 50(4):229-239. DOI: 10.1159/000502446. View

Lee M, Saver J, Chang K, Liao H, Chang S, Ovbiagele B . Low glomerular filtration rate and risk of stroke: meta-analysis. BMJ. 2010; 341:c4249. PMC: 2948650. DOI: 10.1136/bmj.c4249. View

Pereira A, Weiner D, Scott T, Sarnak M . Cognitive function in dialysis patients. Am J Kidney Dis. 2005; 45(3):448-62. DOI: 10.1053/j.ajkd.2004.10.024. View

Saran R, Li Y, Robinson B, Ayanian J, Balkrishnan R, Bragg-Gresham J . US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2015; 66(1 Suppl 1):Svii, S1-305. PMC: 6643986. DOI: 10.1053/j.ajkd.2015.05.001. View

Murray A, Bell E, Tupper D, Davey C, Pederson S, Amiot E . The Brain in Kidney Disease (BRINK) Cohort Study: Design and Baseline Cognitive Function. Am J Kidney Dis. 2016; 67(4):593-600. PMC: 5271565. DOI: 10.1053/j.ajkd.2015.11.008. View

Freedman B, Divers J, Whitlow C, Bowden D, Palmer N, Smith S . Subclinical Atherosclerosis Is Inversely Associated With Gray Matter Volume in African Americans With Type 2 Diabetes. Diabetes Care. 2015; 38(11):2158-65. PMC: 4613911. DOI: 10.2337/dc15-1035. View

OLone E, Connors M, Masson P, Wu S, Kelly P, Gillespie D . Cognition in People With End-Stage Kidney Disease Treated With Hemodialysis: A Systematic Review and Meta-analysis. Am J Kidney Dis. 2016; 67(6):925-35. DOI: 10.1053/j.ajkd.2015.12.028. View

Sharma A, Yabes J, Al Mawed S, Wu C, Stilley C, Unruh M . Impact of Cognitive Function Change on Mortality in Renal Transplant and End-Stage Renal Disease Patients. Am J Nephrol. 2016; 44(6):462-472. PMC: 5143182. DOI: 10.1159/000451059. View

Sharma K, Karl B, Mathew A, Gangoiti J, Wassel C, Saito R . Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease. J Am Soc Nephrol. 2013; 24(11):1901-12. PMC: 3810086. DOI: 10.1681/ASN.2013020126. View

10.

Rawlings A, Sharrett A, Schneider A, Coresh J, Albert M, Couper D . Diabetes in midlife and cognitive change over 20 years: a cohort study. Ann Intern Med. 2014; 161(11):785-93. PMC: 4432464. DOI: 10.7326/M14-0737. View

11.

Davenport A . What are the causes of the ill effects of chronic hemodialysis? Balancing risks: blood pressure targets, intradialytic hypotension, and ischemic brain injury. Semin Dial. 2013; 27(1):13-5. DOI: 10.1111/sdi.12153. View

12.

Mapstone M, Cheema A, Fiandaca M, Zhong X, Mhyre T, MacArthur L . Plasma phospholipids identify antecedent memory impairment in older adults. Nat Med. 2014; 20(4):415-8. PMC: 5360460. DOI: 10.1038/nm.3466. View

13.

Hsu F, Sink K, Hugenschmidt C, Williamson J, Hughes T, Palmer N . Cerebral Structure and Cognitive Performance in African Americans and European Americans With Type 2 Diabetes. J Gerontol A Biol Sci Med Sci. 2018; 73(3):407-414. PMC: 5861881. DOI: 10.1093/gerona/glx255. View

14.

Kurella Tamura M, Tam K, Vittinghoff E, Raj D, Sozio S, Rosas S . Inflammatory Markers and Risk for Cognitive Decline in Chronic Kidney Disease: The CRIC Study. Kidney Int Rep. 2017; 2(2):192-200. PMC: 5399682. DOI: 10.1016/j.ekir.2016.10.007. View

15.

Huffman K, Shah S, Stevens R, Bain J, Muehlbauer M, Slentz C . Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women. Diabetes Care. 2009; 32(9):1678-83. PMC: 2732163. DOI: 10.2337/dc08-2075. View

16.

Chen G, Cai L, Chen B, Liang J, Lin F, Li L . Serum level of endogenous secretory receptor for advanced glycation end products and other factors in type 2 diabetic patients with mild cognitive impairment. Diabetes Care. 2011; 34(12):2586-90. PMC: 3220856. DOI: 10.2337/dc11-0958. View

17.

Wang H, Hung S, Sung J, Hung K, Wang J . Risk of stroke in long-term dialysis patients compared with the general population. Am J Kidney Dis. 2013; 63(4):604-11. DOI: 10.1053/j.ajkd.2013.10.013. View

18.

Wolfgram D . Intradialytic Cerebral Hypoperfusion as Mechanism for Cognitive Impairment in Patients on Hemodialysis. J Am Soc Nephrol. 2019; 30(11):2052-2058. PMC: 6830804. DOI: 10.1681/ASN.2019050461. View

19.

Barzilay J, Lovato J, Murray A, Williamson J, Ismail-Beigi F, Karl D . Albuminuria and cognitive decline in people with diabetes and normal renal function. Clin J Am Soc Nephrol. 2013; 8(11):1907-14. PMC: 3817915. DOI: 10.2215/CJN.11321112. View

20.

Murray A, Seliger S, Lakshminarayan K, Herzog C, Solid C . Incidence of stroke before and after dialysis initiation in older patients. J Am Soc Nephrol. 2013; 24(7):1166-73. PMC: 3699827. DOI: 10.1681/ASN.2012080841. View